Natural Compound Methyl Protodioscin Suppresses Proliferation and Inhibits Glycolysis in Pancreatic Cancer

Abstract EN

Methyl protodioscin (MPD) is one of the main bioactive components in the plant of Dioscoreaceae.

MPD has been demonstrated to possess antitumor activities.

However, its role in pancreatic cancer and the underlying molecular mechanisms are poorly defined.

In the present study, we demonstrated that MPD inhibited proliferation and promoted apoptosis of pancreatic cancer.

Furthermore, our results demonstrated that MPD decreased oncogene c-Myc in protein level and resulted in concomitant reduction in glycolysis.

In vivo assays with xenograft mouse model further confirmed the in vitro observations, which indicated that MPD inhibited 18FDG uptake in tumors formed by subcutaneously injection of MIA PaCa-2 cells.

Collectively, our present study uncovered novel antitumor functions of MPD in pancreatic cancer and provided the possible molecular mechanism.